Nisun International (NISN) has signed a strategic cooperation agreement with Beijing Tong Ren Tang, marking its entrance into the traditional Chinese medicine, or TCM, supply chain. The partnership focuses on sourcing Cornus officinalis, or Chinese dogwood, an ingredient in TCM. Nisun plans to broaden its sourcing efforts to include other essential TCM ingredients. Nisun has also initiated share repurchases under its recently announced $15M buyback program.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NISN: